Study on the Dose-Effect Relationship of Ginger-Partitioned Moxibustion in the Treatment of Allergic Rhinitis
- Conditions
- Allergic rhinitis
- Registration Number
- ITMCTR2100005231
- Lead Sponsor
- Shanghai TCM-Integrated Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- Not specified
1. Men or women aged 18 to 60 years;
2. Those who have perennial allergic rhinitis;
3. Those who meet diagnostic criteria of allergic rhinitis;
4. Those who have not used any drugs or treatment methods for allergic rhinitis 2 weeks before the trial;
5. Those who accept ginger moxibustion treatment;
6. Those who are willing to cooperate with this trial treatment plan;
7. Those who are willing to sign an informed consent form.
1. Those who are allergic to smoke and dust produced by moxibustion;
2. Those who are pregnant, breastfeeding during the study period;
3. Those who have serious disease related to the blood vessel, liver, kidney or haematopoietic system;
4. Those who have mental illness;
5. Those who are complicated with rhinosinusitis, otitis media, nasal polyps, nasal septum deviation and other ENT infections or organic lesions;
6. Those who have asthma and other paroxysmal respiratory diseases and are in the attack period;
7. Those who are participating in the other clinical trials of moxibustion.
Study & Design
- Study Type
- Interventional study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Total Nasal Symptom Score (TNSS);
- Secondary Outcome Measures
Name Time Method Rhino Conjunctivitis Quality of Life Questionnaire (RQLQ);